Production and differential activity of recombinant human wild-type G6PD and G6PD_Viangchan

[1]Carson PE, Flanagan CL, Ickes C, Alving AS. Enzymatic deficiency in primaquine-sensitive erythrocytes. Science. 1956; 124(3220):484–5.CarsonPEFlanaganCLIckesCAlvingASEnzymatic deficiency in primaquine-sensitive erythrocytesScience19561243220484510.1126/science.124.3220.484.bSearch in Google Scholar

[2]Efferth T, Fabry U, Glatte P, Osieka R. Increased induction of apoptosis in mononuclear cells of a glucose-6-phosphate dehydrogenase deficient patient. J Mol Med (Berl). 1995; 73:47–9.EfferthTFabryUGlattePOsiekaRIncreased induction of apoptosis in mononuclear cells of a glucose-6-phosphate dehydrogenase deficient patientJ Mol Med (Berl)19957347910.1007/BF00203619Search in Google Scholar

[3]Zhang J, Cao M, Yang W, Sun F, Xu C, Yin L, et al. Inhibition of glucose-6-phosphate dehydrogenase could enhance 1, 4-benzoquinone-induced oxidative damage in K562 cells. Oxid Med Cell Longev. 2016; 2016:3912515. doi: 10.1155/2016/3912515ZhangJCaoMYangWSunFXuCYinLInhibition of glucose-6-phosphate dehydrogenase could enhance 1, 4-benzoquinone-induced oxidative damage in K562 cellsOxid Med Cell Longev20162016391251510.1155/2016/3912515Open DOISearch in Google Scholar

[4]McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969; 244:6049–55.McCordJMFridovichISuperoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)J Biol Chem196924460495510.1016/S0021-9258(18)63504-5Search in Google Scholar

[5]Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008; 371(9606):64–74.CappelliniMDFiorelliGGlucose-6-phosphate dehydrogenase deficiencyLancet20083719606647410.1016/S0140-6736(08)60073-2Search in Google Scholar

[6]Beutler E. Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood. 2008; 111:16–24.BeutlerEGlucose-6-phosphate dehydrogenase deficiency: a historical perspectiveBlood2008111162410.1182/blood-2007-04-07741218156501Search in Google Scholar

[7]Valencia SH, Ocampo ID, Arce-Plata MI, Recht J, Arévalo-Herrera M. Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia. Malar J. 2016; 15:291. doi: 10.1186/s12936-016-1343-1ValenciaSHOcampoIDArce-PlataMIRechtJArévalo-HerreraMGlucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of ColombiaMalar J20161529110.1186/s12936-016-1343-1488087927225440Open DOISearch in Google Scholar

[8]WHO Scientific Group on the Standardization of Procedures for the Study of Glucose-6-Phosphate Dehydrogenase and World Health Organization. Standardization of procedures for the study of glucose-6-phosphate dehydrogenase: report of a WHO Scientific Group [meeting held in Geneva from 5 to 10 December 1966] [Internet] Geneva: World Health Organization; 1967 [cited 2020 Mar 24]. Available from: https://apps.who.int/iris/handle/10665/40660WHO Scientific Group on the Standardization of Procedures for the Study of Glucose-6-Phosphate Dehydrogenase and World Health OrganizationStandardization of procedures for the study of glucose-6-phosphate dehydrogenase: report of a WHO Scientific Group [meeting held in Geneva from 5 to 10 December 1966] [Internet]GenevaWorld Health Organization1967[cited 2020 Mar 24]. Available from: https://apps.who.int/iris/handle/10665/40660Search in Google Scholar

[9]Beutler E, Yoshida A. Genetic variation of glucose-6-phosphate dehydrogenase: a catalog and future prospects. Medicine (Baltimore). 1988; 67:311–34.BeutlerEYoshidaAGenetic variation of glucose-6-phosphate dehydrogenase: a catalog and future prospectsMedicine (Baltimore)1988673113410.1097/00005792-198809000-000033045479Search in Google Scholar

[10]Singh H. Glucose-6-phosphate dehydrogenase deficiency: a preventable cause of mental retardation. Br Med J (Clin Res Ed). 1986; 292(6517):397–8.SinghHGlucose-6-phosphate dehydrogenase deficiency: a preventable cause of mental retardationBr Med J (Clin Res Ed)19862926517397810.1136/bmj.292.6517.39713393653080188Search in Google Scholar

[11]Hon A, Balakrishnan S, Ahmad Z. Hyperbilirubinemia and erythocytic glucose 6 phosphate dehydrogenase deficiency in Malaysian children. Med J Malaysia. 1989; 44:30–4.HonABalakrishnanSAhmadZHyperbilirubinemia and erythocytic glucose 6 phosphate dehydrogenase deficiency in Malaysian childrenMed J Malaysia198944304Search in Google Scholar

[12]Sulaiman AM, Saghir SAM, Al-Hassan FM, Yusoff NM, Zaki A-HA. Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in a university community in Malaysia. Trop J Pharm Res. 2013; 12:363–7.SulaimanAMSaghirSAMAl-HassanFMYusoffNMZakiA-HAMolecular characterization of glucose-6-phosphate dehydrogenase deficiency in a university community in MalaysiaTrop J Pharm Res201312363710.4314/tjpr.v12i3.14Search in Google Scholar

[13]Ainoon O, Yu Y, Muhriz AA, Boo N, Cheong S, Hamidah N. Glucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian Malays. Hum Mutat. 2003; 21:1. doi: 10.1002/humu.9103AinoonOYuYMuhrizAABooNCheongSHamidahNGlucose-6-phosphate dehydrogenase (G6PD) variants in Malaysian MalaysHum Mutat200321110.1002/humu.910312497642Open DOISearch in Google Scholar

[14]Yusoff NM, Shirakawa T, Nishiyama K, Ee CK, Isa MN, Matsuo M. G6PD Viangchan and G6PD Mediterranean are the main variants in G6PD deficiency in the Malay population of Malaysia. Southeast Asian J Trop Med Public Health. 2004; 34(Suppl. 3):135–7.YusoffNMShirakawaTNishiyamaKEeCKIsaMNMatsuoMG6PD Viangchan and G6PD Mediterranean are the main variants in G6PD deficiency in the Malay population of MalaysiaSoutheast Asian J Trop Med Public Health200434Suppl. 31357Search in Google Scholar

[15]Poon M-C, Hall K, Scott CW, Prehal JT. G6PD Viangchan: a new glucose 6-phosphate dehydrogenase variant from Laos. Hum Genet. 1988; 78:98–9.PoonM-CHallKScottCWPrehalJTG6PD Viangchan: a new glucose 6-phosphate dehydrogenase variant from LaosHum Genet19887898910.1007/BF002912463338798Search in Google Scholar

[16]World Health Organization Working Group. Glucose-6-phosphate dehydrogenase deficiency. WHO Bulletin OMS. 1989; 67:601–11. Available from: https://apps.who.int/iris/handle/10665/47019World Health Organization Working GroupGlucose-6-phosphate dehydrogenase deficiencyWHO Bulletin OMS19896760111Available from: https://apps.who.int/iris/handle/10665/47019Search in Google Scholar

[17]Gómez-Manzo S, Terrón-Hernández J, De la Mora-De la Mora I, González-Valdez A, Marcial-Quino J, García-Torres I, et al. The stability of G6PD is affected by mutations with different clinical phenotypes. Int J Mol Sci. 2014; 15:21179–201.Gómez-ManzoSTerrón-HernándezJDe la Mora-De la MoraIGonzález-ValdezAMarcial-QuinoJGarcía-TorresIThe stability of G6PD is affected by mutations with different clinical phenotypesInt J Mol Sci2014152117920110.3390/ijms151121179426421925407525Search in Google Scholar

[18]Roos D, van Zwieten R, Wijnen JT, Gómez-Gallego F, de Boer M, Stevens D, et al. Molecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase Volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood. 1999; 94:2955–62.RoosDvan ZwietenRWijnenJTGómez-GallegoFde BoerMStevensDMolecular basis and enzymatic properties of glucose 6-phosphate dehydrogenase Volendam, leading to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infectionsBlood199994295562Search in Google Scholar

[19]Huang Y, Choi MY, Au SWN, Au DMY, Lam VMS, Engel PC. Purification and detailed study of two clinically different human glucose 6-phosphate dehydrogenase variants, G6PD_Plymouth and G6PD_Mahidol: evidence for defective protein folding as the basis of disease. Mol Genet Metabol. 2008; 93:44–53.HuangYChoiMYAuSWNAuDMYLamVMSEngelPCPurification and detailed study of two clinically different human glucose 6-phosphate dehydrogenase variants, G6PD_Plymouth and G6PD_Mahidol: evidence for defective protein folding as the basis of diseaseMol Genet Metabol200893445310.1016/j.ymgme.2007.08.12217959407Search in Google Scholar

[20]Wang X-T, Lam VM, Engel PC. Functional properties of two mutants of human glucose 6-phosphate dehydrogenase, R393G and R393H, corresponding to the clinical variants G6PD Wisconsin and Nashville. Biochim Biophys Acta. 2006; 1762:767–74.WangX-TLamVMEngelPCFunctional properties of two mutants of human glucose 6-phosphate dehydrogenase, R393G and R393H, corresponding to the clinical variants G6PD Wisconsin and NashvilleBiochim Biophys Acta200617627677410.1016/j.bbadis.2006.06.01416934959Search in Google Scholar

[21]Wang X-T, Engel PC. Clinical mutants of human glucose 6-phosphate dehydrogenase: impairment of NADP⁺ binding affects both folding and stability. Biochim Biophys Acta. 2009; 1792:804–9.WangX-TEngelPCClinical mutants of human glucose 6-phosphate dehydrogenase: impairment of NADP⁺ binding affects both folding and stabilityBiochim Biophys Acta20091792804910.1016/j.bbadis.2009.05.00319465117Search in Google Scholar

[22]Boonyuen U, Chamchoy K, Swangsri T, Saralamba N, Day NP, Imwong M. Detailed functional analysis of two clinical glucose-6-phosphate dehydrogenase (G6PD) variants, G6PD_Viangchan and G6PD_{Viangchan+Mahidol}: decreased stability and catalytic efficiency contribute to the clinical phenotype. Mol Genet Metabol. 2016; 118:84–91.BoonyuenUChamchoyKSwangsriTSaralambaNDayNPImwongMDetailed functional analysis of two clinical glucose-6-phosphate dehydrogenase (G6PD) variants, G6PD_Viangchan and G6PD_{Viangchan+Mahidol}: decreased stability and catalytic efficiency contribute to the clinical phenotypeMol Genet Metabol2016118849110.1016/j.ymgme.2016.03.008489429627053284Search in Google Scholar

[23]Gómez-Manzo S, Marcial-Quino J, Vanoye-Carlo A, Serrano-Posada H, González-Valdez A, Martínez-Rosas V, et al. Functional and biochemical characterization of three recombinant human glucose-6-phosphate dehydrogenase mutants: Zacatecas, Vanua-Lava and Viangchan. Int J Mol Sci. 2016; 17:787. doi: 10.3390/ijms17050787Gómez-ManzoSMarcial-QuinoJVanoye-CarloASerrano-PosadaHGonzález-ValdezAMartínez-RosasVFunctional and biochemical characterization of three recombinant human glucose-6-phosphate dehydrogenase mutants: Zacatecas, Vanua-Lava and ViangchanInt J Mol Sci20161778710.3390/ijms17050787488160327213370Open DOISearch in Google Scholar

[24]Boonyuen U, Chamchoy K, Swangsri T, Junkree T, Day NPJ, White NJ, Imwong M. A trade off between catalytic activity and protein stability determines the clinical manifestations of glucose-6-phosphate dehydrogenase (G6PD) deficiency. Int J Biol Macromol. 2017; 104(Pt A):145–56.BoonyuenUChamchoyKSwangsriTJunkreeTDayNPJWhiteNJImwongMA trade off between catalytic activity and protein stability determines the clinical manifestations of glucose-6-phosphate dehydrogenase (G6PD) deficiencyInt J Biol Macromol2017104Pt A1455610.1016/j.ijbiomac.2017.06.002562599628583873Search in Google Scholar

[25]Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25:1605–12.PettersenEFGoddardTDHuangCCCouchGSGreenblattDMMengECFerrinTEUCSF Chimera—a visualization system for exploratory research and analysisJ Comput Chem20042516051210.1002/jcc.2008415264254Search in Google Scholar

[26]Scouras AD, Daggett V. The Dynameomics rotamer library: amino acid side chain conformations and dynamics from comprehensive molecular dynamics simulations in water. Protein Sci. 2011; 20:341–52.ScourasADDaggettVThe Dynameomics rotamer library: amino acid side chain conformations and dynamics from comprehensive molecular dynamics simulations in waterProtein Sci2011203415210.1002/pro.565304841921280126Search in Google Scholar

[27]Hess B, Kutzner C, van der Spoel D, Lindahl E. GROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation. J Chem Theory Comput. 2008; 4(3):435–47.HessBKutznerCvan der SpoelDLindahlEGROMACS 4: algorithms for highly efficient, load-balanced, and scalable molecular simulationJ Chem Theory Comput2008434354710.1021/ct700301q26620784Search in Google Scholar

[28]Rizvi SM, Shakil S, Haneef M. A simple click by click protocol to perform docking: AutoDock 4.2 made easy for non-bioinformaticians. EXCLI J. 2013; 12:831–57.RizviSMShakilSHaneefMA simple click by click protocol to perform docking: AutoDock 4.2 made easy for non-bioinformaticiansEXCLI J20131283157Search in Google Scholar

[29]Kotaka M, Gover S, Vandeputte-Rutten L, Au SW, Lam VM, Adams MJ. Structural studies of glucose-6-phosphate and NADP⁺ binding to human glucose-6-phosphate dehydrogenase. Acta Crystallogr D Biol Crystallogr. 2005; 61:495–504.KotakaMGoverSVandeputte-RuttenLAuSWLamVMAdamsMJStructural studies of glucose-6-phosphate and NADP⁺ binding to human glucose-6-phosphate dehydrogenaseActa Crystallogr D Biol Crystallogr20056149550410.1107/S090744490500235015858258Search in Google Scholar

[30]Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011; 51:2778–86.LaskowskiRASwindellsMBLigPlot+: multiple ligand-protein interaction diagrams for drug discoveryJ Chem Inf Model20115127788610.1021/ci200227u21919503Search in Google Scholar

[31]Rao ST, Rossmann MG. Comparison of super-secondary structures in proteins. J Mol Biol. 1973; 76:241–56.RaoSTRossmannMGComparison of super-secondary structures in proteinsJ Mol Biol1973762415610.1142/9789814513357_0013Search in Google Scholar

[32]Hanukoglu I. Proteopedia: Rossmann fold: a beta-alpha-beta fold at dinucleotide binding sites. Biochem Mol Biol Educ. 2015; 43:206–9.HanukogluIProteopedia: Rossmann fold: a beta-alpha-beta fold at dinucleotide binding sitesBiochem Mol Biol Educ201543206910.1002/bmb.2084925704928Search in Google Scholar

[33]Gómez-Manzo S, Terrón-Hernández J, de la Mora-de la Mora I, García-Torres I, López-Velázquez G, Reyes-Vivas H, Oria-Hernández J. Cloning, expression, purification and characterization of His-Tagged human glucose-6-phosphate dehydrogenase: a simplified method for protein yield. Protein J. 2013; 32:585–92.Gómez-ManzoSTerrón-HernándezJde la Mora-de la MoraIGarcía-TorresILópez-VelázquezGReyes-VivasHOria-HernándezJCloning, expression, purification and characterization of His-Tagged human glucose-6-phosphate dehydrogenase: a simplified method for protein yieldProtein J2013325859210.1007/s10930-013-9518-x24146346Search in Google Scholar

[34]Minucci A, Giardina B, Zuppi C, Capoluongo E. Glucose-6-phosphate dehydrogenase laboratory assay: how, when, and why? IUBMB Life. 2009; 61:27–34.MinucciAGiardinaBZuppiCCapoluongoEGlucose-6-phosphate dehydrogenase laboratory assay: how, when, and why?IUBMB Life200961273410.1002/iub.13718942156Search in Google Scholar

[35]von Seidlein L, Auburn S, Espino F, Shanks D, Cheng Q, McCarthy J, et al. Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar J. 2013; 12:112. doi: 10.1186/1475-2875-12-112von SeidleinLAuburnSEspinoFShanksDChengQMcCarthyJReview of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop reportMalar J20131211210.1186/1475-2875-12-112361683723537118Open DOISearch in Google Scholar

[36]Blacker TS, Duchen MR. Investigating mitochondrial redox state using NADH and NADPH autofluorescence. Free Radic Biol Med. 2016; 100:53–65.BlackerTSDuchenMRInvestigating mitochondrial redox state using NADH and NADPH autofluorescenceFree Radic Biol Med2016100536510.1016/j.freeradbiomed.2016.08.010514580327519271Search in Google Scholar